APA

Leslie C. P., Biagetti M., Bison S., Bromidge S. M., Di Fabio R., Donati D., Falchi A., Garnier M. J., Jaxa-Chamiec A., Manchee G., Merlo G., Pizzi D. A., Stasi L. P., Tibasco J., Vong A., Ward S. E. & Zonzini L. (20140415). Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist. : Journal of medicinal chemistry.

Chicago

Leslie Colin P, Biagetti Matteo, Bison Silvia, Bromidge Steven M, Di Fabio Romano, Donati Daniele, Falchi Alessandro, Garnier Martine J, Jaxa-Chamiec Albert, Manchee Gary, Merlo Giancarlo, Pizzi Domenica A, Stasi Luigi P, Tibasco Jessica, Vong Antonio, Ward Simon E and Zonzini Laura. 20140415. Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist. : Journal of medicinal chemistry.

Harvard

Leslie C. P., Biagetti M., Bison S., Bromidge S. M., Di Fabio R., Donati D., Falchi A., Garnier M. J., Jaxa-Chamiec A., Manchee G., Merlo G., Pizzi D. A., Stasi L. P., Tibasco J., Vong A., Ward S. E. and Zonzini L. (20140415). Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist. : Journal of medicinal chemistry.

MLA

Leslie Colin P, Biagetti Matteo, Bison Silvia, Bromidge Steven M, Di Fabio Romano, Donati Daniele, Falchi Alessandro, Garnier Martine J, Jaxa-Chamiec Albert, Manchee Gary, Merlo Giancarlo, Pizzi Domenica A, Stasi Luigi P, Tibasco Jessica, Vong Antonio, Ward Simon E and Zonzini Laura. Discovery of 1-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, selective, and orally active 5-HT1A/B/D receptor antagonist. : Journal of medicinal chemistry. 20140415.